CD4 and neoplasm: In this context, different groups have addressed the effect of host pro-inflammatory responses in human papillomavirus (HPV)-related diseases [29, 34], which might promote lesion progression to more advanced stages and affect tumor fate by diverse mechanisms including the direct participation of unusual immune cells, as would be the case of the CD4+NKG2D+ T cells.